A private equity firm focused on real estate investments involved in the cluster formation of science based companies primarily operating in the life science industry.
Alexandria Venture Investments has made over 50 investments. A large investment was made on Jan 30, 2019, when they invested $60M in Dewpoint Therapeutics.
Alexandria Venture Investments has had 10 exits. Alexandria Venture Investments's most notable exits include TCR2, Moderna Therapeutics, and Gritstone Oncology.